A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Modified-Release Formulations of AZD1446 in Young and Elderly Healthy Japanese Volunteers After Oral Single and Repeated Doses
Phase of Trial: Phase I
Latest Information Update: 27 Dec 2010
At a glance
- Drugs AZD 1446 (Primary)
- Indications Alzheimer's disease; Depressive disorders
- Focus Adverse reactions
- 27 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Oct 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 17 Sep 2010 New trial record